Rituximab use in systemic lupus erythematosus pneumonitis and a review of current reports

Internal Medicine Journal

Volumn 36, Issue 4, 2006, Pages 260-262

  Lim, S W ^a   Gillis, D ^a   Smith, W ^a   Hissaria, P ^a   Greville, H ^a   Peh, C A ^b  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

B cell depletion; Pneumonitis; Rituximab; Systemic autoimmune disease; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; HYDROXYCHLOROQUINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; COURSE EVALUATION; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DISEASE COURSE; DISEASE EXACERBATION; DOSE CALCULATION; DRUG DOSE REDUCTION; DRUG ERUPTION; DYSPNEA; FEMALE; GENERAL CONDITION IMPROVEMENT; HUMAN; HUMAN TISSUE; INTERSTITIAL LUNG DISEASE; LIVER TOXICITY; MEDICAL EXAMINATION; MOUTH ULCER; NEPHROTOXICITY; PANNICULITIS; PNEUMONIA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; SPIROMETRY; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS PNEUMONITIS; THORAX PAIN;

ADULT; ANTIBODIES, MONOCLONAL; EXERCISE TOLERANCE; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PNEUMONIA;

EID: 33645422715     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2006.01055.x     Document Type: Review

References (18)

1. Liang MH Socher SA Larson MG Schur PH Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus Arthritis Rheum 1989 32 1107 18
2. Edwards JC Szczepanski L Szechinski J Filipowicz-Sosnowska A Emery P Close DR et al Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis N Engl J Med 2004 350 2572 81
3. Looney RJ Anolik JH Campbell D Felgar RE Young F Arend LJ et al B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab Arthritis Rheum 2004 50 2580 89
4. Gottenberg JE Guillevin L Lambotte O Combe B Allanore Y Cantagrel A et al Tolerance and short-term efficacy of rituximab in 43 patients with systemic autoimmune diseases Ann Rheum Dis 2005 64 913 20
5. Anolik J Sanz I Looney RJ B cell depletion therapy in systemic lupus erythematosus Curr Rheumatol Rep 2003 5 350 56
6. Smith GC Jayne DRW A prospective, open-label trial of B-cell depletion with rituximab in refractory systemic lupus erythematosus [abstract] J Am Soc Nephrol 2003 14 SA-PO379
7. Albert DA Khan SR Stansberry J Tsai D Eisenberg RA A phase I trial of rituximab (anti-CD20) for treatment of systemic lupus erythematosus Arthritis Rheum 2003 48 3659
8. Leandro MJ Ehrenstein MR Edwards JCW Manson J Cambridge G Isenberg D et al Treatment of refractory lupus nephritis with B lymphocyte depletion [abstract] Arthritis Rheum 2003 48 Suppl 9 924
9. Sfifakis PP Boletis JN Lionaki S Vigklis V Fragiadaki KG Iniotaki A et al Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down regulation of the T cell co-stimulatory molecule CD40 ligand Arthritis Rheum 2005 52 501 13
10. Tokunaga M Fujii K Saito S Nakayamada S Tsujimura S Nawata M et al Down-regulation of CD40 and CD80 on B cells in patients with life-threatening systemic lupus erythematosus after successful treatment with rituximab Rheumatology 2005 44 176 82
11. Looney RJ Anolik J Sanz I Treatment of SLE with anti-CD20 monoclonal antibody Curr Dir Autoimmun 2005 8 193 205
12. Silverman GJ Anti-CD20 therapy in systemic lupus erythematosus: a step closer to the clinic Arthritis Rheum 2005 52 371 7
13. Looney RJ Treating human autoimmune disease by depleting B cells Ann Rheum Dis 2002 61 863 6
14. Mabthera TGA Approved Product Information, 18th February 2005
15. Keane MP Lynch JP Pleuropulmonary manifestations of systemic lupus erythematosus Thorax 2000 55 159 66
16. Leandro MJ Edwards JC Cambridge G Ehrenstein MR Isenberg DA An open study of B lymphocyte depletion in systemic lupus erythematosus Arthritis Rheum 2002 46 2673 7
17. Albert DA Khan SR Stansberry J Kolasinski S Tsai D Kamoun M et al A phase I trial of rituximab (anti-CD20) for treatment of systemic lupus erythematosus Arthritis Rheum 2004 50 Suppl 9 Abstract 1125
18. Van der Kolk LE Baars JW Prins MH van Oers MHJ Rituximab treatment results in impaired secondary humoral immune responsiveness Blood 2002 100 2257 9